ConductScience.org, home

Paper3098415

Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.

Jordan VC and 2 others. Cancer Res, 1987. Cited by 157 papers, by iCite.

Cite this record

ConductScience Library. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer. Papers, record 3098415. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3098415

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
PubMed
Journal
Cancer Res
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
157
iCite
Relative citation ratio, by iCite
5.2
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jordan VCV C
2Fritz NFN F
3Tormey DCD C

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
TamoxifenMajor topic
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Estrogens
Female
Follicle Stimulating Hormone
Humans
Luteinizing Hormone
Lymphatic Metastasis
Menopause
Menstruation
Progesterone
Prolactin
Time Factors

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 14520NCI NIH HHSUnited StatesP01CA014520PubMed and NIHNIH RePORTER
P01 20432PHS HHSUnited StatesPubMedPubMed
P02CA014520NIHNIH RePORTER
P30CA014520NIHNIH RePORTER
P60CA014520NIHNIH RePORTER

Download CSV of grants

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.

PMIDTitleJournalYearIn PapersSource
42213241Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.Curr Treat Options Oncol2026https://conductscience.org/library/papers/42213241PubMed
35216831Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors.Fertil Steril2022https://conductscience.org/library/papers/35216831PubMed
31897335Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy.J Breast Cancer2019https://conductscience.org/library/papers/31897335PubMed
29228681Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis.Oncotarget2017https://conductscience.org/library/papers/29228681PubMed
27462500Prediction of ovarian function in premenopausal breast cancer patients with amenorrhoea after chemotherapy: a simple clinical score.Springerplus2016https://conductscience.org/library/papers/27462500PubMed
25269699Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapy.J Natl Cancer Inst2014https://conductscience.org/library/papers/25269699PubMed
25258390Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients.J Natl Cancer Inst2014https://conductscience.org/library/papers/25258390PubMed
25084324From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs).Steroids2014https://conductscience.org/library/papers/25084324PubMed
24805199Influence of the length and positioning of the antiestrogenic side chain of endoxifen and 4-hydroxytamoxifen on gene activation and growth of estrogen receptor positive cancer cells.J Med Chem2014https://conductscience.org/library/papers/24805199PubMed
24504100Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study.Osteoporos Int2014https://conductscience.org/library/papers/24504100PubMed
23840510Tamoxifen and ovarian function.PLoS One2013https://conductscience.org/library/papers/23840510PubMed
23150063Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project.Cancer Epidemiol Biomarkers Prev2013https://conductscience.org/library/papers/23150063PubMed
19918920Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors.Cancer2010https://conductscience.org/library/papers/19918920PubMed
19749156G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells.Mol Endocrinol2009https://conductscience.org/library/papers/19749156PubMed
18427357Body size affects measures of ovarian reserve in late reproductive age women.Menopause2008https://conductscience.org/library/papers/18427357PubMed
14709804Tamoxifen is an estrogen antagonist on gonadotropin secretion and responsiveness of the hypothalamic-pituitary- adrenal axis in female monkeys.Endocrine2003https://conductscience.org/library/papers/14709804PubMed
11122897Fertility and the impact of systemic therapy on hormonal status following treatment for breast cancer.Curr Oncol Rep2000https://conductscience.org/library/papers/11122897PubMed
10718636Regulation of heat shock protein 72 kDa and 90 kDa in human breast cancer MDA-MB-231 cells.Mol Cell Biochem2000https://conductscience.org/library/papers/10718636PubMed
10665480Antiestrogens--tamoxifen, SERMs and beyond.Invest New Drugs1999https://conductscience.org/library/papers/10665480PubMed
10396232Gynaecological effects of tamoxifen.J Clin Pathol1999https://conductscience.org/library/papers/10396232PubMed

See all 33 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
PRL5617PubTator's text mininghttps://conductscience.org/library/genes/5617NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3098415

GET https://conductscience.org/api/papers/v1/3098415/cited_by?page=2